A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue

Published:2023-08-01 Issue:3 Volume:208 Page:301-311
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Vanderbeke Lore¹²^ORCID,Jacobs Cato²,Feys Simon¹²^ORCID,Reséndiz-Sharpe Agustin³,Debaveye Yves⁴⁵,Hermans Greet⁴²,Humblet-Baron Stephanie¹,Lagrou Katrien¹⁶⁷,Meersseman Philippe¹²,Peetermans Marijke¹²,Seldeslachts Laura³^ORCID,Vanstapel Arno⁸,Vande Velde Greetje³,Van Wijngaerden Eric¹⁹,Wilmer Alexander¹²,Verbeken Erik³⁸,De Hertogh Gert³⁸,Wauters Joost¹²

Affiliation:

1. Department of Microbiology, Immunology, and Transplantation,

2. Medical Intensive Care Unit,

3. Department of Imaging and Pathology, and

4. Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium; and

5. Department of Intensive Care Medicine,

6. Department of Laboratory Medicine,

7. National Reference Center for Mycosis,

8. Department of Pathology, and

9. Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium

Funder

Fonds Wetenschappelijk Onderzoek

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202208-1570OC

Reference35 articles.

1. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

2. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

3. Invasive pulmonary aspergillosis complicating severe influenza

4. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial

5. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Uncertainty: Managing Influenza-Associated Invasive Pulmonary Aspergillosis in an Intensive Care Unit;Journal of Fungi;2024-09-07

2. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients;The Lancet Respiratory Medicine;2024-09

3. Prevalence of co‐existent COVID‐19‐associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID‐19‐associated pulmonary mucormycosis (CAPM);Mycoses;2024-05

4. Die Mukormykose in Zeiten von COVID-19: Risiken und Herausforderungen;DMW - Deutsche Medizinische Wochenschrift;2024-04-24

5. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants;Annals of Intensive Care;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3